Han Ying: Clinical Trials

3 trials sponsored by Han Ying, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed, 1 enrolling by invitation. 2 Phase 2, 2 Phase 3, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Active not recruiting 1, Enrolling by invitation 1
Phase 32Active not recruiting 1, Enrolling by invitation 1
Early Phase 11Completed 1

Follow Han Ying: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Multicenter, Randomized, Controlled Trial of Prednisone Combined With Ursodeoxycholic Acid in the Treatment of Primary Biliary Cholangitis With Moderate to Severe Interface Hepatitis Characteristics
Prednisone, UDCA (Ursodeoxycholic acid) - Primary Biliary Cholangitis (PBC)
Phase 2 / Phase 3Enrolling by invitationHan Ying2442024-10-302026-10-29
A Pilot Study of Fenofibrate and Ursodeoxycholic Acid in the Treatment of Newly Diagnosed Primary Biliary Cholangitis
Fenofibrate, UDCA (Ursodeoxycholic acid) - Primary Biliary Cholangitis (PBC)
Early Phase 1CompletedHan Ying302024-09-142026-08-05
Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis
Fenofibrate, Placebo, UDCA - Primary Biliary Cholangitis
Phase 2 / Phase 3Active not recruitingHan Ying1842023-08-212026-10-29

Conditions studied

Liver Cirrhosis, Biliary (3)

Interventions

Fenofibrate (2)  ·  Ursodeoxycholic Acid (2)  ·  Prednisone (1)

Countries

China (3)